Contact

Advancing medicines
that matter.

From the first preclinical batch to commercial launch and beyond, Resilience keeps your biologics and sterile drug product programs moving toward the patients who need them.

Frame 2147234455

1

supply chain from thaw to distribution in the greater Cincinnati, Ohio area

220M+

sterile drug product units released

600+

batches executed each year

50+

global markets served

50L - 2,000L

single-use commercial scale bioreactors

1M+

square feet of manufacturing facilities in North America

Built on Experience.
Focused on What's Next.

Resilience is the CDMO partner for biotech and pharma companies at every stage of development and manufacturing.

Our teams bring more than 20 years of expertise across biologics drug substance and sterile drug product, with device assembly, labeling, and packaging capabilities that extend through market-ready finished goods. Across our North American network, experienced teams, advanced technology, and proven manufacturing operations turn promising science into dependable supply. And from day one, we plan for what comes next, giving every program the best chance to become a medicine that matters.

Get to Know Resilience
Resilience team member - visual inspection
Resilience and Lilly partnership announcement event image.

Resilience and Lilly Invest $750 Million to Increase US-Manufactured Medicine Supply

Resilience and Lilly are expanding a partnership that began in 2023. A new $750 million investment grows our Ohio operations and adds KwikPen® device manufacturing.

Find the Right Path for Your Program

Whether you're preparing your first IND or supplying global markets, we match our capabilities and operating model to your stage and scale.

Pharma

Commercial supply you can plan around

From launch onward, you receive high-volume sterile drug product manufacturing for a single product or a full portfolio, with digitally enabled operations that keep supply steady even as demand changes. Our robust quality and regulatory compliance enable seamless development, production, and distribution across North America, the EU, Asia, and the Middle East. Sustainability programs at our sites support the supplier standards your procurement teams track.

Pharma Solutions

Biotech

A CDMO built around your timeline and program

Get direct access to the scientists and quality experts working on your molecule, plus flexible support as you move from early clinical phases to commercial launch. We provide phase-appropriate development and advanced quality systems, ensuring your lead candidate receives the same dedicated technical attention and personalized care as any commercial-scale product.

Biotech Solutions

Not Sure Where to Start?

See our capabilities and sites in one place.

Download Our Corporate Fact Sheet
Orange Particle Swoosh CTA

Capabilities for Clinical and Commercial Programs

Start at any phase of your program. Choose drug substance, drug product, or both, whether that means beginning with development and tech transfer, scaling up later, or bringing us material you've already made. 

In Ohio, product goes from thaw through filling, inspection, device assembly, and final packaging, ready for distribution. Because we run our services on shared quality systems and dedicated program management, you get consistent standards whichever path you take.

Two laboratory technicians in blue protective scrubs chatting in a modern facility

The Teams Behind Every Program

We bring rigorous quality systems and disciplined execution to each milestone you set.

01

Proven Quality

100% regulatory inspection success rate across our network for more than a decade. Tenured regulatory teams and a robust digital quality management system, rigorously verified and aligned with global inspection requirements (eg. FDA cGMP, FDA pre-approval, Health Canada, PMDA, and EMA inspections, plus EU Annex 1 compliance).

02

Technical Depth

Demonstrated expertise across process and analytical development, formulation, process characterization, technology transfer, and validation. We bring together deep technical knowledge and practical experience to help overcome development challenges, accelerate timelines, and move promising therapies toward the clinic sooner.

03

Reliable Execution

 <60 days from formulation to labeled, market-ready units through automation and digital platforms from manufacturing to quality. A program manager and technical lead guide your program through each stage gate, backed by manufacturing and operations teams who deliver on their commitments.

04

Direct Access

15 years average technical and scientific team tenure across our network. Work directly with the scientists and quality leads who know your molecule, and take clear ownership and accountability from start to finish. We use centralized data systems to give you transparent, accurate updates when you ask.

Let's Talk About Your Program.

Tell us your stage, timeline, and expected volumes. We'll connect you with the team who will do the work.

Speak With an Expert
Frame 2147234452